Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4 - Concepedia

Concepedia

Publication | Closed Access

Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4

172

Citations

42

References

2004

Year

Jack W. Coburn, Hla M. Maung, Logan Elangovan, Michael J. Germain, Jill S. Lindberg, Stuart M. Sprague, Mark E. Williams, Charles W. Bishop

American Journal of Kidney Diseases

Secondary HyperparathyroidismPth LevelsMedicineRenal PathologyPharmacologyParathyroid HormoneParathyroid DiseaseParathyroid GlandChronic Kidney DiseaseNephrology

References

	Year	Citations

Page 1

Page 1